Popovits Kimberly J
SEC-identified person · CIK 1333482 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Kardigan, Inc. KARD | Director | filed 2026 - 2026 |
| 10x Genomics, Inc. TXG | Director | filed 2020 - 2026 |
| Kiniksa Pharmaceuticals, Ltd. KNSA | Director | filed 2018 - 2026 |
| Rhythm Pharmaceuticals, INC. SRYTM | Director | filed 2026 - 2026 |
| Exact Sciences Corp EXAS | Director | filed 2025 - 2026 |
| Talis Biomedical Corp TLIS | Director · Interim CEO | filed 2021 - 2023 |
| Myokardia, Inc. MYOK | Director | filed 2017 - 2020 |
| Genomic Health INC GHDX | Director · President and COO | filed 2006 - 2019 |
| ZS Pharma, Inc. ZSPH | Director | filed 2015 - 2015 |
| Oruka Therapeutics, Inc. ORKA | Director | filed 2006 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.